- Home
- GOVX vs NAII Comparison
GOVX vs NAII Comparison
Compare GOVX & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- NAII
- Stock Information
- Founded
- GOVX 2001
- NAII 1980
- Country
- GOVX United States
- NAII United States
- Employees
- GOVX N/A
- NAII N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- NAII Medicinal Chemicals and Botanical Products
- Sector
- GOVX Health Care
- NAII Health Care
- Exchange
- GOVX Nasdaq
- NAII Nasdaq
- Market Cap
- GOVX 23.8M
- NAII 28.0M
- IPO Year
- GOVX N/A
- NAII 1987
- Fundamental
- Price
- GOVX $2.26
- NAII $4.15
- Analyst Decision
- GOVX Strong Buy
- NAII
- Analyst Count
- GOVX 5
- NAII 0
- Target Price
- GOVX $14.20
- NAII N/A
- AVG Volume (30 Days)
- GOVX 715.7K
- NAII 9.7K
- Earning Date
- GOVX 11-12-2024
- NAII 02-11-2025
- Dividend Yield
- GOVX N/A
- NAII N/A
- EPS Growth
- GOVX N/A
- NAII N/A
- EPS
- GOVX N/A
- NAII N/A
- Revenue
- GOVX $3,090,161.00
- NAII $112,977,000.00
- Revenue This Year
- GOVX N/A
- NAII N/A
- Revenue Next Year
- GOVX $150.51
- NAII N/A
- P/E Ratio
- GOVX N/A
- NAII N/A
- Revenue Growth
- GOVX N/A
- NAII N/A
- 52 Week Low
- GOVX $1.09
- NAII $4.11
- 52 Week High
- GOVX $11.18
- NAII $7.26
- Technical
- Relative Strength Index (RSI)
- GOVX 44.80
- NAII 39.86
- Support Level
- GOVX $2.17
- NAII $4.20
- Resistance Level
- GOVX $2.50
- NAII $4.33
- Average True Range (ATR)
- GOVX 0.17
- NAII 0.14
- MACD
- GOVX -0.04
- NAII -0.01
- Stochastic Oscillator
- GOVX 18.33
- NAII 0.00
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.